Femoral Nerve Block Compared to Exparel in Total Knee Replacement
Status:
Unknown status
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The main objective of the study is to determine if intrarticular injection with liposomal
bupivicaine (Exparel) provides better postoperative pain relief and functional outcome
following total knee replacement (TKR) than the current standard New England Baptist Hospital
regimen of femoral nerve block combined with intraarticular injection of a standard
bupivicaine solution.